S. 470 · 116th Congress
Medicare at 50 Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
StabenowSponsor20 cosponsors · 20 D
D
Brown
TB
D
Baldwin
RB
D
Blumenthal
CB
D
Booker
BC
D
Cardin
RD
D
Durbin
TD
D
Duckworth
KG
D
Gillibrand
MH
D
Heinrich
KH
D
Harris
AK
D
Klobuchar
PL
D
Leahy
EM
D
Markey
JM
D
Merkley
GP
D
Peters
JR
D
Reed
JS
D
Shaheen
TS
D
Smith
SW
D
Whitehouse
BC
D
Casey19 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill establishes a Medicare buy-in option for certain qualifying individuals and also repeals restrictions relating to prescription drug prices under the Medicare prescription drug benefit.
What it does: CRS summary · Introduced in Senate · Feb 13, 2019
Medicare at 50 Act
This bill establishes a Medicare buy-in option for certain qualifying individuals and also repeals restrictions relating to prescription drug prices under the Medicare prescription drug benefit.
Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare & Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option.
The bill also repeals provisions that prohibit the CMS from negotiating the prices of prescription drugs or from establishing a formulary under the Medicare prescription drug benefit.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicare at 50 Act
Latest action (Feb 13, 2019): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Feb 13, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.